BioPharma Resources

Company · RHHBY

Roche (Genentech)

Includes drugs filed under related and acquired sponsor names. Trials are searched under: Hoffmann-La Roche; Genentech, Inc.; Spark Therapeutics, Inc..

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

95

49 still marketed

Novel approvals

51

Approvals since 2021

85

Originals and new uses

Phase 3 trials

642

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

Drugs in development (58)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline
  • GiredestrantRO7197597, GDC-9545Phase 316 trials

    Roche (Genentech) · Early Breast Cancer, Breast Cancer, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer

  • AfimkibartRO7790121, RVT-3101Phase 312 trials

    Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis

  • TiragolumabMTIG7192A, RO7092284Phase 311 trials

    Roche (Genentech) · Hepatocellular Carcinoma, Rectal Neoplasms, Rectal Cancer

  • AtirmociclibPF-07220060Phase 39 trials

    Pfizer · Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer

  • DivarasibGDC-6036, RO7435846Phase 38 trials

    Roche (Genentech) · Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer, Non-small Cell Lung Cancer

  • FenebrutinibRO7010939, GDC-0853Phase 36 trials

    Roche (Genentech) · Relapsing Multiple Sclerosis, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive

  • LHRH AgonistPhase 36 trials

    Roche (Genentech) · Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, Early Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

  • IpatasertibRO5532961, GDC-0068Phase 35 trials

    Roche (Genentech) · Metastatic Breast Cancer, Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer, Ovarian Cancer

  • rHuPH20Phase 35 trials

    Bristol Myers Squibb · Melanoma, Relapsing-remitting Multiple Sclerosis, Clear Cell Renal Cell Carcinoma

  • CevostamabRO7187797Phase 34 trials

    Roche (Genentech) · Multiple Myeloma

  • TrontinemabRO7126209, RG6102Phase 34 trials

    Roche (Genentech) · Alzheimers Disease, Alzheimer's Disease

  • AstegolimabPhase 33 trials

    Roche (Genentech) · Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD)

  • bypassing agentsClotting factor concentrates, CFCPhase 33 trials

    Sanofi · Hemophilia, Von Willebrand Disease, Type 3

  • LHRHLuteinizing hormone-releasing hormone agonist, Luteinizing Hormone-Releasing Hormone AgonistsPhase 33 trials

    AstraZeneca · ER-Positive HER2-Negative Breast Cancer, Ovarian Cancer

  • PegozaferminBIO89-100Phase 33 trials

    Roche (Genentech) · Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Severe Hypertriglyceridemia

  • PrasinezumabRO7046015, PRX002Phase 33 trials

    Roche (Genentech) · Parkinson's Disease, Parkinsons Disease

  • RO7204239Phase 33 trials

    Roche (Genentech) · Obesity, Overweight, Overweight With One Weight Related Comorbidity

  • AAV2-hRPE65v2voretigene neparvovec-rzylPhase 32 trials

    Roche (Genentech) · Leber Congenital Amaurosis, Inherited Retinal Dystrophy Due to RPE65 Mutations

  • BL-8040Phase 32 trials

    BioLineRx, Ltd. · Multiple Myeloma, Pancreatic Adenocarcinoma

  • CDK4Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Advanced ER+/HER2- Breast Cancer, Breast Cancer

  • EmactuzumabPhase 32 trials

    Roche (Genentech) · Cancer, TGCT

  • NXT007Zemocimig, RO7589655Phase 32 trials

    Roche (Genentech) · Hemophilia A

  • RituxumabPhase 32 trials

    Roche (Genentech) · Diffuse Large B-cell Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma

  • TPST-1120Phase 32 trials

    Roche (Genentech) · Advanced Liver Cancers, Hepatocellular Carcinoma (HCC)

  • VamikibartRO7200220Phase 32 trials

    Roche (Genentech) · Uveitic Macular Edema

Recruiting Phase 3 trials

Largest first.

Marketed drugs (49)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.